This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

IMRISneuro Purchased By University Hospital Tübingen

Stocks in this article: IM IMRS

-- European Expansion Continues --

WINNIPEG, March 2 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS") today announced the sale of IMRISneuro to the University Hospital Tübingen, located in Tübingen, Germany.

University Hospital Tübingen is one of the leading centres of medicine at university level in Germany. The German Science Council has certified that the Hospital and Faculty of Medicine provide outstanding services in the fields of research, teaching and health-care, and that both institutions are pacemakers in the field of medicine at University level in the Federal Republic of Germany.

The IMRISneuro system will be an integral part of the Hospital's neurosurgical facilities and features a 1.5 Tesla MR scanner operating in a fully integrated suite that allows the scanner to move into an operating room and provide high resolution MR images on demand - before, during and after procedures without moving the patient. University Hospital Tübingen will be the first hospital in Germany to make this technology available to patients.

Designed specifically for neurosurgery, IMRISneuro provides timely images during procedures to assist clinicians in making better decisions for improved patient outcomes. IMRISneuro does not require the patient to be transported for scanning, so the optimum patient positioning is always maintained. Clinical workflow and access to the patient is not impacted and the MR scanner is removed completely from the operating room when imaging is complete. This ensures a high degree of safety for both the patient and the surgical environment.

"High field intraoperative MR imaging applications have continued to evolve over the last decade," said Dr. M. Tatagiba, Professor of Neurosurgery and Chairman and Director of the Department of Neurosurgery at University Hospital Tübingen. "Several technological improvements have optimized this imaging modality to its current standard. Of all available intraoperative imaging techniques, we believe iMRI with a 1.5T magnet provides the most accurate intraoperative images available today."

Dr. G.C. Feigl, Consultant Neurosurgeon and Head of Center for Intraoperative Imaging Technologies at the Hospital's Department of Neurosurgery added, "After several months of intense planning and construction we are very proud that the first state of the art iMRI unit of its kind in Europe with a mobile 1.5T magnet will be opened in our Department on April 15th 2011."

"The University Hospital Tübingen has a strong reputation in the German medical community for providing high quality services," said Hartmut Warnken, IMRIS Vice President and General Manager, Europe and Middle East. "We are delighted to be equipping the Hospital's neurosurgeons with the leading intra operative MR imaging solution available and we are confident that the system will contribute significantly to the Hospital's neurosurgical capabilities."


IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions. These solutions feature fully integrated surgical and interventional suites that incorporate magnetic resonance, fluoroscopy and computed tomography to deliver on demand imaging during procedures. The Company's systems serve the neurosurgical, cardiovascular and neurovascular markets and have been selected by leading medical institutions around the world.


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs